Endometrial Adenofibroma in a Patient Receiving Toremifene: A Case Report
endometrial adenofibroma; breast cancer; toremifene; magnetic resonance image
Journal
Current medical imaging
ISSN: 1573-4056
Titre abrégé: Curr Med Imaging
Pays: United Arab Emirates
ID NLM: 101762461
Informations de publication
Date de publication:
2024
2024
Historique:
received:
06
11
2022
revised:
26
03
2023
accepted:
28
03
2023
medline:
15
11
2023
pubmed:
12
5
2023
entrez:
12
5
2023
Statut:
ppublish
Résumé
Adenofibroma is a rare benign Müllerian mixed tumor composed of epithelial and mesenchymal cells. This tumor may occasionally be associated
with toremifene therapy which is used as an adjuvant drug for breast cancer. We describe a case of a 55-year-old woman with adenofibroma of the endometrium. This patient was receiving toremifene after surgery and
neoadjuvant chemotherapy for breast cancer. She underwent a total abdominal hysterectomy and bilateral salpingectomy. There was no evidence of
tumor residual or recurrence at 32 months of MRI follow-up. In conclusion, we report a rare case of endometrial adenofibroma in a patient receiving toremifene. It must be borne in mind that long-term
toremifene therapy may increase the frequency of endometrial neoplasms.
Identifiants
pubmed: 37170977
pii: CMIR-EPUB-131218
doi: 10.2174/1573405620666230426143620
doi:
Substances chimiques
Toremifene
7NFE54O27T
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
e260423216211Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.